| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 07/01/2010 | US20100168088 Pyrrolidine derivatives as nk-3 receptor antagonists |
| 07/01/2010 | US20100168070 Compounds for the treatment of alzheimer's disease |
| 07/01/2010 | US20100168062 Quinoxaline Derivatives as Tyrosine Kinase Activity Inhibitors |
| 07/01/2010 | US20100168005 Pyridin-3-yl derivatives as immunomodulating agents |
| 07/01/2010 | US20100167925 Substituted Azolin-2-yl-Amino Compounds |
| 07/01/2010 | US20100167279 Unsymmetrical cyanine dyes for high resolution nucleic acid melting analysis |
| 07/01/2010 | US20100166881 Novel IDO Inhibitors and Methods of Use Thereof |
| 07/01/2010 | US20100166765 Benzoquinazoline derivatives |
| 07/01/2010 | US20100166710 Compositions and Methods for Inducing Neuronal Differentiation |
| 07/01/2010 | US20100166706 Hcv ns-3 serine protease inhibitors |
| 07/01/2010 | CA2772760A1 Small molecule inhibitors of necroptosis |
| 07/01/2010 | CA2748099A1 7-phenoxychroman carboxylic acid derivatives |
| 07/01/2010 | CA2747795A1 Isoquinoline derivative |
| 07/01/2010 | CA2747784A1 Pharmaceutical compounds |
| 07/01/2010 | CA2745952A1 Dihydropyridone amides as p2x7 modulators |
| 07/01/2010 | CA2745866A1 Dihydropyridone ureas as p2x7 modulators |
| 07/01/2010 | CA2745565A1 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
| 07/01/2010 | CA2728118A1 Compounds for treatment of cancer |
| 06/30/2010 | EP2202231A1 2,3-dihydroiminoisoindole derivative |
| 06/30/2010 | EP2201009A2 Monomethine dyes |
| 06/30/2010 | EP2201008A1 Pyridyl sulfonamides as modulators of ion channels |
| 06/30/2010 | EP2201007A1 Cannabinoid receptor ligands |
| 06/30/2010 | EP2201006A1 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them |
| 06/30/2010 | EP2200990A1 Gamma secretase modulators |
| 06/30/2010 | EP2200609A1 Compounds for the treatment of metabolic disorders |
| 06/30/2010 | EP2200440A1 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds |
| 06/30/2010 | EP1841763B1 5-heteroaryl thiazoles and their use as pi3k inhibitors |
| 06/30/2010 | EP1838308B1 [4-(heteroaryl)piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 06/30/2010 | EP1368323B1 Pyrimidine matrix metalloproteinase inhibitors |
| 06/30/2010 | CN1533276B Use of thiazole derivatives for preparing medicine for protecting mitochondria |
| 06/30/2010 | CN101765598A Fungicide N-5-membered fused heteroaryl-methylene-N-cycloalkyl-carboxamide derivatives |
| 06/30/2010 | CN101765597A Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase |
| 06/30/2010 | CN101765594A 1, 3-thiazol-2 (3H) -ylidene compounds as cannabinoid receptor ligands |
| 06/30/2010 | CN101765593A 2-iminoisothiazole derivatives as cannabinoid receptor ligands |
| 06/30/2010 | CN101765585A antibacterial agents |
| 06/30/2010 | CN101765371A pesticides and uses thereof |
| 06/30/2010 | CN101759695A Thiazole derivative containing pyrazole ring and preparation method and application thereof |
| 06/30/2010 | CN101759694A 2-(1, 3-disubstituted phenyl-4-pyrazolyl) benzothiazole compound as well as preparation method and application thereof |
| 06/29/2010 | US7745639 Dihydropyrazoles; anticarcinogenic agents can be synergistically combined with one or more active ingredients; side effect reduction |
| 06/29/2010 | US7745632 containing an indole compound |
| 06/29/2010 | US7745623 Cyclic amide derivative, and its production and use |
| 06/29/2010 | US7745479 1,5-substituted indol-2-yl amide derivatives |
| 06/29/2010 | US7745475 Heteroaryl benzamide derivatives as GLK activators |
| 06/29/2010 | US7745472 Dimethylsulfamic Acid 2-bromo-4-{[(4-cyano-phenyl)-[1,2,4]triazol-4-ylamino]methyl}phenyl Ester, used as effective sulfatase and/or aromatase inhibitors, and as modulators of cell cycling and modulators of apoptosis; therapy of breast, prostate, ovarian or endometrial cancer |
| 06/29/2010 | US7745462 5-[R-2-(1S,2S-2-Cyclohexylcyclopentylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one, useful for treating conditions that are prevented or alleviated by activation of the adrenergic recptors |
| 06/29/2010 | US7745454 Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
| 06/29/2010 | US7745453 Hydroxypyrimidinone derivatives having inhibitory activity against HIV integrase |
| 06/29/2010 | US7745443 antagonists of the interaction between the plasma protein von Willebrand factor (vWF) and the blood platelet receptor glycoprotein Ib-IX-V complex, exhibit anticoagulant effect and are suitable for the therapy and prophylaxis of cardiovascular disorders |
| 06/29/2010 | US7745442 Methods of reducing risk of infection from pathogens |
| 06/29/2010 | US7745437 Compounds and compositions as protein kinase inhibitors |
| 06/29/2010 | US7745436 Disalt inhibitors of IL-12 production |
| 06/29/2010 | CA2557856C 3-'4-heterocyclyl-1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| 06/29/2010 | CA2539541C Isoquinolinone potassium channel inhibitors |
| 06/29/2010 | CA2455987C Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 06/29/2010 | CA2345985C Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives,processes for their preparation, pharmaceuticals comprising these compounds and their use |
| 06/24/2010 | WO2010071837A1 Pyrazine derivatives useful as inhibitors of atr kinase |
| 06/24/2010 | WO2010071783A1 Thiazoles as cannabinoid receptor ligands |
| 06/24/2010 | WO2010070523A1 Monocarbams |
| 06/24/2010 | WO2010070510A2 A process for preparing quetiapine fumarate |
| 06/24/2010 | WO2010070068A2 Organic compounds |
| 06/24/2010 | WO2010069794A1 Thiadiazole-substituted arylamides |
| 06/24/2010 | WO2010069494A1 Use of 5-pyridin-4yl(1,3)thiazole for treating phytopathogenic fungi |
| 06/24/2010 | WO2010069266A1 Heterocyclic nitrogenous or oxygenous compounds with insecticidal activity formed from dialdehydes and their preparation and uses thereof |
| 06/24/2010 | WO2010069147A1 Dihydropyrimidine derivatives, compositions thereof and their use |
| 06/24/2010 | WO2010069124A1 Amide thiazole derivative, preparation method and uses thereof |
| 06/24/2010 | US20100160629 Cyclic amide derivative, and its production and use |
| 06/24/2010 | US20100160627 (2,3-cis)-3-amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one; for treatment of neurological disorders related to amyloid beta protein production such as Alzheimer's disease; inhibit gamma secretase and thereby inhibit the production of amyloid beta protein |
| 06/24/2010 | US20100160395 Cyclopropyl compounds |
| 06/24/2010 | US20100160374 N-(2-Hydroxyethyl)-N-Methyl-4-(Quinolin-8-yl(1-(Thiazol-4-ylmethyl)Piperidin-4-ylidene)Methyl)Benzamide |
| 06/24/2010 | US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160336 Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors |
| 06/24/2010 | US20100160330 Novel bicyclic heterocycles useful as selective androgen receptor modulators |
| 06/24/2010 | US20100160328 New compounds useful for dpp-iv enzyme inhibition |
| 06/24/2010 | US20100160324 Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases |
| 06/24/2010 | US20100160316 Quinazolines useful as modulators of ion channels |
| 06/24/2010 | US20100160308 Thiazolyl-Benzimidazoles |
| 06/24/2010 | US20100160303 Carbazole carboxamide compounds useful as kinase inhibitors |
| 06/24/2010 | US20100160302 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them |
| 06/24/2010 | US20100160290 Pharmaceutical composition for treating alzheimer's disease |
| 06/24/2010 | US20100160289 Sulfonamides as trpm8 modulators |
| 06/24/2010 | US20100160287 Compounds useful as inhibitors of janus kinases |
| 06/24/2010 | US20100160283 Heteroaryl-substituted alkyne compounds and method of use |
| 06/24/2010 | US20100159596 Small molecule compounds for stem cell differentiation |
| 06/24/2010 | CA2747354A1 Organic compounds |
| 06/24/2010 | CA2747303A1 Use of 5-pyridin-4yl(1,3)thiazole for treating phytopathogenic fungi |
| 06/24/2010 | CA2747252A1 Pyrazine derivatives useful as inhibitors of atr kinase |
| 06/24/2010 | CA2745459A1 Thiazoles as cannabinoid receptor ligands |
| 06/24/2010 | CA2745290A1 Thiadiazole-substituted arylamides |
| 06/24/2010 | CA2744447A1 A process for preparing quetiapine fumarate |
| 06/23/2010 | EP2198867A1 Pyrimidine-based compounds useful as GSK-3 inhibitors |
| 06/23/2010 | EP2198710A1 Use of 5-pyridin-4yl-(1,3) thiazoles for combating phytopathogenic fungi |
| 06/23/2010 | EP2197878A2 Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases |
| 06/23/2010 | EP2197876A1 Thiazole and oxazole kinase inhibitors |
| 06/23/2010 | EP2197875A1 Diacylglycerol acyltransferase inhibitors |
| 06/23/2010 | EP2197874A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use |
| 06/23/2010 | EP2197873A1 Compounds and compositions as modulators of gpr119 activity |
| 06/23/2010 | EP2197872A1 Phenylisoquinoline and phenylquinazoline derivatives for the treatment of bone diseases |
| 06/23/2010 | EP2197860A1 New compounds as adenosine a1 receptor antagonists |
| 06/23/2010 | EP2197446A2 Preparation of ziprasidone hydrochloride monohydrate |